|Articles|October 7, 2020
High Throughput DAR Determination of Brentuximab Vedotin
Author(s)YMC Europe GmbH
YMC’s latest HIC column is used to analyse the DAR of Brentuximab Vedotin allowing higher flow rates and shorter run times thanks to the pressure resistant particle.
Trending on LCGC International
1
How Should You Respond to FDA 483 Observations?
2
Py-GC–MS Reveals Microplastics in Playgrounds
3
Q-2DMS: Two-Dimensional Mass Spectrometry Extended to Commercial QTOF Platforms
4
Highlights from the HPLC2026 Conference through the Lens of LC Troubleshooting
5